Real-World Persistence with Tocilizumab Compared to Other Subcutaneous Biologic Disease-Modifying Antirheumatic Drugs Among Patients with Rheumatoid Arthritis Switching from Another Biologic

enthalten in: Rheumatology and therapy | 2020

von Best, J. | Vlad, S. | Tominna, L. | +1